Evidence map›Paper›PMID 36362619›Full record

ArticleJournal of clinical medicine2022

The Role and Place of Antioxidants in the Treatment of Male Infertility Caused by Varicocele.

Marek Szymański, Piotr Domaracki, Angelika Szymańska, Tomasz Wandtke, Robert Szyca, Łukasz Brycht, Karolina Wasilow, Wojciech Jan Skorupski

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marek SzymańskiDepartment of Women's Health and Reproductive Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-067 Bydgoszcz, Poland.
Piotr DomarackiDepartment of Women's Health and Reproductive Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-067 Bydgoszcz, Poland.ORCID 0000-0002-2745-530X
Angelika SzymańskaNZOZ Medical Center, Clinic of Infertility Treatment "Genesis", 85-435 Bydgoszcz, Poland.
Tomasz WandtkeNZOZ Medical Center, Clinic of Infertility Treatment "Genesis", 85-435 Bydgoszcz, Poland.
Robert SzycaClinic of Surgery and Oncological Surgery, 10th Military Research Hospital and Polyclinic, IPHC, 85-681 Bydgoszcz, Poland.
Łukasz BrychtDepartment of Women's Health and Reproductive Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-067 Bydgoszcz, Poland.
Karolina WasilowDepartment of Women's Health and Reproductive Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-067 Bydgoszcz, Poland.
Wojciech Jan Skorupski1st Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.
Nicolaus Copernicus University · PL1 Military Clinical Hospital with Outpatient Clinic · PLPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inability to become pregnant for at least 1 year despite regular unprotected intercourse may indicate infertility of one or both partners. This problem affects approximately 10-20% of couples worldwide, regardless of race, with male infertility reported to account for 25-60% of cases. Among the most common pathological causes of male infertility is the presence of varicocele and chronic infections of the male reproductive system. This study was performed using data collected at the Genesis Infertility Treatment Clinic, Bydgoszcz, Poland, between 1 January 2015 and 30 June 2017. A total of 163 men meeting the inclusion criteria were selected and divided into the idiopathic infertility group (78 men) and varicocele-related infertility group (85 men). All patients received treatment with a male fertility supplement containing a combination of 1725 mg of L-carnitine fumarate, 500 mg of acetyl-L-carnitine, 90 mg of vitamin C, 20 mg of coenzyme Q10, 10 mg of zinc, 200 µg of folic acid, 50 µg of selenium, and 1.5 µg of vitamin B12 (Proxeed

Indexed as

antioxidant therapymale infertilityoxidative stressvaricocele

Identifiers

PMID36362619
PMCPMC9655278
OpenAlexW4307944151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.